It is an orally active, selective angiotensin II receptor (AT1) antagonist indicated for the treatment of primary hypertension in adults to reduce cardiovascular risk. This product has passed the national generic drug consistency evaluation.

Primary Indications

Adult primary hypertension, reducing cardiovascular risk

The Main Contraindication To Medication

Individuals with known hypersensitivity to the active ingredient or any excipient of this product; Women in the second and third trimesters of pregnancy (the middle three months and final three months of gestation) and lactating women; Patients with biliary tract obstructive disease; Patients with severe hepatic impairment; This product must not be used concomitantly with alendronate in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) <60 ml/min/1.73m²).

Dosage Form

Tablet